Industry Trends
A single-click search on a comprehensive list of research & regulatory trends, unmet and rare diseases, and countries ensures well-connected data with graphical views and simple data exports — all in a single platform.
- Trend Analysis — view drugs, clinical trials, companies, drug sales & estimates, review designations, patent expiry.
- Drugs by top biopharma companies, by stage, molecule nature, indication and more.
- Trials by top sponsors, indications, phase, status and more with Trial Analytics.
- Companies by revenue, R&D expense, financials, news, deals, contacts and subsidiary information.
- Technology details to see trends in drug discovery and delivery techniques.
- Key patents analysis based on active ingredient, composition, method of use and device innovations.
- Future milestone events on key drugs and clinical trials.
Benefits for Healthcare Players
Start-up and Contract Research & Manufacturing Companies
Monthly newsletter with drug developments and contacts keep them up-to-date with material events and business leads. Market size projections help you to get the business scope for raising investment. Search for planned trials with CROs as collaborator within your sales territory.
Biopharma Companies
Informed with competitor events and execute corporate planning by keeping a track on future drug and clinical trials milestones expected from your competitors. Customize your key events tracking based on companies in the same technology or disease or target.
Generic Drugs and API manufacturer
Helps you to plan drug portfolio management or strategy based on key pipeline class of drugs (future market share) and disease market by country. Support you with planned trials by disease, sponsors/collaborators.
API, & Intermediates Manufactures
Key pipeline class of drugs (future market share); disease market by key countries. Generics by active ingredient in US, EU, & Japan, and Patent expiry for key pipeline and marketed drugs.
Financial Firms
Keep track on early stage biotech companies and proactively evaluate companies based on future events and clinical trial success rates. Set alerts for material events at companies within your portfolio or competing companies that may affect the valuation of your portfolio companies.